Belgium Budget Squeeze: Pharma Sector Faces Strategic Funding Cuts

Belgian government signals broad budget austerity amid slowing growth and higher interest rates, with pharmaceutical sector funding under scrutiny as medicines account for only ~1% of GDP. The PM warns all citizens will share the burden, indicating potential cuts to strategic sectors. Uncertainty remains over specific policy measures and their impact on the pharma industry.